Association between acute graft-versus-host disease and the likelihood of reaching different hemagglutinin titer endpoints
| Titer endpoint . | Patient group . | Acute GvHD . | Univariate RR . | P value . | 95% CI . |
|---|---|---|---|---|---|
| IgG-undiluted | MRD | Grades 0-I | 1.0 | — | — |
| Grades II-IV | 1.89 | .002 | (1.26, 2.83) | ||
| MUD | Grades 0-I | 1.0 | — | — | |
| Grades II-IV | 1.26 | .20 | (0.88, 1.81) | ||
| IgM-undiluted | MRD | Grades 0-I | 1.0 | — | — |
| Grades II-IV | 1.71 | .019 | (1.09, 2.68) | ||
| MUD | Grades 0-I | 1.0 | — | — | |
| Grades II-IV | 1.39 | .14 | (0.90, 2.16) | ||
| IgG/IgM-nil | MRD | Grades 0-I | 1.0 | — | — |
| Grades II-IV | 2.22 | .02 | (1.12, 4.39) | ||
| MUD | Grades 0-I | 1.0 | — | — | |
| Grades II-IV | 1.59 | .17 | (0.81, 3.11) |
| Titer endpoint . | Patient group . | Acute GvHD . | Univariate RR . | P value . | 95% CI . |
|---|---|---|---|---|---|
| IgG-undiluted | MRD | Grades 0-I | 1.0 | — | — |
| Grades II-IV | 1.89 | .002 | (1.26, 2.83) | ||
| MUD | Grades 0-I | 1.0 | — | — | |
| Grades II-IV | 1.26 | .20 | (0.88, 1.81) | ||
| IgM-undiluted | MRD | Grades 0-I | 1.0 | — | — |
| Grades II-IV | 1.71 | .019 | (1.09, 2.68) | ||
| MUD | Grades 0-I | 1.0 | — | — | |
| Grades II-IV | 1.39 | .14 | (0.90, 2.16) | ||
| IgG/IgM-nil | MRD | Grades 0-I | 1.0 | — | — |
| Grades II-IV | 2.22 | .02 | (1.12, 4.39) | ||
| MUD | Grades 0-I | 1.0 | — | — | |
| Grades II-IV | 1.59 | .17 | (0.81, 3.11) |
GvHD = graft-versus-host disease; RR = relative risks.
See Table 2 for abbreviations.